Lansoprazole
Product Images NDC 21695-652

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 21695-652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (C119ed19 5dc6 4c03 B705 2616c65ef041 01)

Chemical structure of lansoprazole, showing its molecular arrangement with labeled functional groups including a sulfoxide, benzimidazole, and substituted pyridine ring.*

FDA Label Image

Figure (C119ed19 5dc6 4c03 B705 2616c65ef041 02)

Line graph showing mean severity of day heartburn by study day for evaluable patients. The x-axis represents days from start of treatment, ranging from -5 to 60. The y-axis shows mean severity of day heartburn from 0 (none) to 3 (severe). Three lines compare placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD, illustrating heartburn severity decreasing over treatment days, with both Lansoprazole groups showing lower severity than placebo.*

FDA Label Image

Figure (C119ed19 5dc6 4c03 B705 2616c65ef041 03)

A line graph titled 'Mean Severity of Night Heartburn By Study Day For Evaluable Patients' showing severity levels over 60 days from treatment start. The y-axis represents mean severity (0 to 1.8), with values for placebo and lansoprazole tablets at 15 mg and 30 mg once daily. Data lines show decreasing heartburn severity trends for the treatments compared to placebo.*

FDA Label Image

Lansoprazole 15mg (C119ed19 5dc6 4c03 B705 2616c65ef041 04)

Lansoprazole 16 mg delayed-release capsules in a packaging label showing a quantity of 30 capsules. The label includes the proprietary name Lansoprazole, strength 16 mg, form as DR capsules, and labeler Rebel Distributors Corp. Additional label elements include storage instructions and prescription status RX Only.*

FDA Label Image

Lansoprazole 30mg (C119ed19 5dc6 4c03 B705 2616c65ef041 05)

Packaging label for Lansoprazole 30mg delayed-release capsules. The label states a quantity of 30 capsules. It includes product ID PL065230 and notes the capsules contain 30mg of Lansoprazole as enteric-coated granules. The label is from Physician Partner, with packaging details indicating Manufacturer Takeda Ireland Ltd, Kerry, Ireland, and packager Physician Partner, Thousand Oaks, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.